Anxiety treatment for Deerfield Beach — SSRI dosing done right, CBT that works.

RECO Integrated Psychiatry is a 22-minute drive up A1A or Federal Highway from Deerfield Beach — close enough for weekly visits during SSRI titration, far enough to separate treatment from home and work. Diagnoses are named against DSM-5-TR criteria using GAD-7, PDSS, LSAS, and Y-BOCS, not filed as generic "anxiety." SSRI doses are targeted to the anxiety range — sertraline 150-200 mg, escitalopram 20 mg — and CBT referrals are matched to the disorder: ERP for OCD, interoceptive exposure for panic, in-vivo exposure for social anxiety.

Deerfield Beach sits 13 miles south of RECO Integrated Psychiatry’s Delray Beach office — a 22-minute drive up A1A or Federal Highway that many clients say makes weekly care feasible without pulling them out of work or family routines. Adults living in The Cove, Pioneer Park, Hillsboro Beach, Cresthaven, or near Goldcoast Centre make up a steady share of our anxiety referrals, and the geography does something useful: close enough to hold a schedule, far enough that appointments feel like protected clinical time rather than an errand.

The disorder distinctions that change treatment

Generalized anxiety disorder, panic disorder, social anxiety disorder, and OCD are frequently grouped as “anxiety” in casual conversation and in many primary care visits, but they respond to different therapy protocols and often to different medication dosing. RECO’s intake for anxiety treatment uses the GAD-7 for generalized worry, the Panic Disorder Severity Scale (PDSS) for panic frequency and phobic avoidance, the Liebowitz Social Anxiety Scale (LSAS) for interaction and performance fears, and the Yale-Brown Obsessive Compulsive Scale (Y-BOCS) for obsessions and rituals. The evaluation note names the DSM-5-TR primary diagnosis rather than filing a generic “anxiety, unspecified.”

The therapy referral pathway follows the diagnosis. OCD is matched to exposure and response prevention (ERP), not general CBT. Panic disorder is matched to interoceptive exposure — deliberately reproducing feared bodily sensations to break the catastrophic misinterpretation loop. Social anxiety is matched to in-vivo exposure with cognitive restructuring in graded hierarchies. GAD responds to CBT for worry, acceptance and commitment therapy (ACT), and metacognitive therapy.

Comorbid anxiety disorders are the rule rather than the exception. When a client meets criteria for both GAD and social anxiety, or panic and OCD, the plan sequences treatment by severity and functional impact — usually stabilizing the disorder that most disrupts work, sleep, or relationships first, then folding in the second.

SSRI dosing for anxiety versus depression

Effective SSRI doses for anxiety disorders typically sit at the upper end of the depression range. Sertraline for GAD or OCD is titrated toward 150-200 mg, escitalopram toward 20 mg, paroxetine to 40-60 mg, and fluoxetine for OCD is often pushed to 60-80 mg. Under-dosing is one of the most common reasons a client arrives having “failed” an SSRI when in fact they were never on a therapeutic dose for their specific diagnosis.

Anxious clients are also more sensitive to initiation. Activation — jitteriness, insomnia, and briefly worsened anxiety in the first two weeks — is common and can drive early discontinuation if it isn’t anticipated. RECO’s default is to start at half the usual starting dose (sertraline 25 mg, escitalopram 5 mg) with an explicit conversation about what activation feels like, how long it lasts, and when to call.

Titration is slower and target doses are higher, so trials take longer. A fair SSRI trial for anxiety runs 10-12 weeks at target dose, not 4-6. Response is tracked on the same disorder-specific scale used at intake, so the next medication decision is grounded in a repeated measurement rather than a global impression.

Augmentation and second-line options

Partial responders are common, and the augmentation strategy depends on the diagnosis. In GAD, buspirone at 20-60 mg/day is a well-tolerated SSRI augmentation with no dependence risk and a low side-effect burden. In panic disorder, most partial responders benefit more from adding CBT with interoceptive exposure than from stacking medications — the SSRI has done its job when it lowers baseline arousal enough for exposure work to be tolerable.

OCD is handled differently. The evidence for augmenting an SSRI with low-dose aripiprazole (typically 2.5-10 mg) or risperidone in OCD is stronger than the evidence for switching between SSRIs or moving to an SNRI. Y-BOCS is retested at 8-12 weeks after augmentation to decide whether the strategy is working, and clomipramine remains an option for treatment-resistant cases with an appropriate cardiac workup.

Beta-blockers such as propranolol have a defined role in situational performance anxiety — public speaking, structured examinations, musical performance — taken 30-60 minutes before the trigger. Gabapentin and hydroxyzine cover PRN needs for breakthrough anxiety without the dependence and cognitive risks of benzodiazepines, and are the default PRN choices in this practice.

Benzodiazepines — when we do and don’t prescribe

Benzodiazepines have narrow legitimate indications: short-term crisis stabilization, structured taper of a preexisting long-term prescription, and a small subset of panic disorder cases refractory to SSRI, SNRI, and CBT with interoceptive exposure. Outside those indications, the risk profile — dependence, cognitive slowing, falls in older adults, respiratory depression when combined with opioids or alcohol — outweighs the benefit.

Benzodiazepines also blunt the extinction learning that exposure-based CBT relies on. A client taking alprazolam before every exposure session is unlikely to consolidate the new safety learning that makes CBT durable. For clients doing ERP for OCD or interoceptive exposure for panic, standing benzodiazepines are actively counterproductive.

For clients with any personal or family history of substance use disorder, RECO’s default is not to prescribe. When benzodiazepines are indicated, the plan is written with a taper timeline and defined non-benzodiazepine alternatives — hydroxyzine, gabapentin, propranolol, buspirone — and a return visit dedicated to the taper, not open-ended refill maintenance.

What to expect on your first visit

The initial psychiatric evaluation runs 60-75 minutes and covers current symptoms, prior medication and therapy trials, medical and family history, substance use, sleep, and functional impact at work and in relationships. Standardized measures — GAD-7, PDSS, LSAS, Y-BOCS, PHQ-9 for comorbid depression, and ASRS if attention concerns are on the table — are administered so the diagnosis is documented against DSM-5-TR criteria.

Clients leave the first visit with a working diagnosis, a written medication plan (starting dose, target dose, titration schedule, side-effect expectations, and clear instructions on when to call), and a therapy referral matched to the diagnosis when indicated. Follow-up is typically at 2-4 weeks during titration, then every 4-8 weeks once stable. Measurement-based care is the standard: the same scale used at intake is repeated at each follow-up so treatment decisions are anchored in data.

Insurance and getting to RECO from Deerfield Beach

RECO Integrated Psychiatry is in network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS. Benefits are verified before the first visit and any deductible, copay, or coinsurance is quoted in advance so cost is not a surprise. Out-of-network clients receive an itemized superbill formatted for reimbursement submission.

The Delray Beach office is a 22-minute drive from Deerfield Beach — clients from Hillsboro Beach and The Cove often prefer A1A up the coast, while those from Cresthaven, Pioneer Park, and the Goldcoast Centre area tend to take I-95 to the Atlantic Avenue exit or Federal Highway. Telepsychiatry is available for follow-up medication management visits once a client has been evaluated in person; controlled-substance visits and initial evaluations remain in office.

Serving residents of: The Cove, Pioneer Park, Hillsboro Beach, Cresthaven, Goldcoast Centre.